DW is а 72-yeаr-оld femаle presenting fоr evaluatiоn of cycle 2 carboplatin (AUC=5) with paclitaxel given every 3 weeks for ovarian cancer. The patient states she had persistent nausea throughout cycle 1 that continued until Day 7 post-treatment. She states she had 1 episode of emesis on Day 4. Her past medical history is significant for type 2 DM which she states is reasonably well controlled with diet (though of note her labs today are significant for glucose 230 mg/dL). Cycle 1 Day 1: Olanzapine 5 mg PO + aprepitant 125mg PO + ondansetron 24 mg PO + dexamethasone 12 mg PO Days 2-3: aprepitant 80mg PO once daily in the morning Days 2-4: dexamethasone 8 mg PO once daily in the morning; olanzapine 5mg PO once daily at bedtime Breakthrough: prochlorperazine 10 mg PO every 6 hours as needed Additionally, upon discussion, she has ongoing struggles with adherence despite re-education, and she forgot to take all her scheduled post-treatment medications after the last treatment (dexamethasone, aprepitant, and olanzapine). Which of the following would be the best option for prevention of acute and delayed CINV for cycle 2 in this patient?